Skip to main content

Advertisement

Table 1 (abstract P14). National Essential Medicines List (NEML) evolution 1996-2011

From: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies

Year of NEML approval Total number of molecules (excluding duplicates) Total number of molecules (including duplicates) Total number of pharmaceutical forms Rate of pharmaceutical form per molecule Total number of therapeutic categories
1996 106 108 147 1.36 0
2007 475 504 718 1.42 29
2009 519 578 819 1.41 27
2011 576 635 856 1.34 29